0001209191-24-003091.txt : 20240212
0001209191-24-003091.hdr.sgml : 20240212
20240212161915
ACCESSION NUMBER: 0001209191-24-003091
CONFORMED SUBMISSION TYPE: 3/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220103
FILED AS OF DATE: 20240212
DATE AS OF CHANGE: 20240212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hait William
CENTRAL INDEX KEY: 0001904791
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 3/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-03215
FILM NUMBER: 24620208
MAIL ADDRESS:
STREET 1: ONE JOHNSON & JOHNSON PLAZA
CITY: NEW BRUNSWICK
STATE: NJ
ZIP: 08933
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: JOHNSON & JOHNSON
CENTRAL INDEX KEY: 0000200406
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 221024240
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE JOHNSON & JOHNSON PLZ
CITY: NEW BRUNSWICK
STATE: NJ
ZIP: 08933
BUSINESS PHONE: 732-524-2455
MAIL ADDRESS:
STREET 1: ONE JOHNSON & JOHNSON PLZ
CITY: NEW BRUNSWICK
STATE: NJ
ZIP: 08933
3/A
1
doc3a.xml
FORM 3/A SUBMISSION
X0206
3/A
2022-01-03
2022-01-13
0
0000200406
JOHNSON & JOHNSON
JNJ
0001904791
Hait William
ONE JOHNSON & JOHNSON PLAZA
NEW BRUNSWICK
NJ
08933
0
1
0
0
See Remarks
Common Stock
15996
D
This Form 3/A is being filed to correct the number of shares of common stock reported in Table I of the original Form 3 filed on January 13, 2022, as amended by the Form 3/A filed on February 18, 2022 ("Amended Form 3"), which Amended Form 3 inadvertently reported 71,609 shares beneficially owned by the reporting person instead of the 15,996 shares reported herein. This Form 3/A is deemed to update the number of securities reported as beneficially owned in any Forms 4 subsequently filed by the reporting person through the date hereof.
Title: EVP, Chief External Innovation and Medical Officer
/s/ Raavi Deol, as attorney-in-fact for William Hait
2024-02-12